Wide Ranks

GPCR

Structure Therapeutics Inc.

33.75

Top Statistics
Market Cap 1 B Forward PE -53.45 Revenue Growth 0.00 %
Current Ratio 41.38 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -45.51 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 927 M Total Cash Per Share 5.40 Total Debt 4 M
Total Debt To Equity 0.5070 Current Ratio 41.38 Book Value Per Share 9.76
All Measures
Short Ratio 1569.00 % Message Board Id finmb_1673457818 Shares Short Prior Month 10 M
Return On Equity -0.1769 City South San Francisco Uuid 8fb71ef4-0d7a-30de-b9f4-2631f9206cd7
Previous Close 33.74 First Trade Date Epoch Utc 1 B Book Value 9.76
Total Debt 4 M Volume 518558 Price To Book 3.46
Fifty Two Week Low 26.61 Total Cash Per Share 5.40 Shares Short Previous Month Date 1 B
Target Median Price 86.00 Max Age 86400 Recommendation Mean 1.45
Sand P52 Week Change 0.3133 Target Mean Price 85.82 Net Income To Common -100435000
Short Percent Of Float 0.2167 Implied Shares Outstanding 46 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 1 M Average Volume10days 1 M
Total Cash 927 M Next Fiscal Year End 1 B Held Percent Insiders 0.0484
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 33.74 Target Low Price 65.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 38.49 Open 34.00 Free Cashflow -68363752
State CA Dividend Yield 0.00 % Return On Assets -0.1301
Time Zone Short Name EST Trailing Eps -2.16 Day Low 33.09
Address1 601 Gateway Boulevard Shares Outstanding 57 M Price Hint 2
Target High Price 118.00 Website https://structuretx.com 52 Week Change -0.3940
Average Volume 743635 Forward Eps -0.7700 Recommendation Key strong_buy
Compensation As Of Epoch Date 1 B Quick Ratio 4091.60 % Is_sp_500 False
Regular Market Day High 34.24 Profit Margins 0.00 % Debt To Equity 0.5070
Fifty Two Week High 66.38 Day High 34.24 Shares Short 10 M
Regular Market Open 34.00 Industry Key biotechnology Earnings Growth 0.00 %
Revenue Growth 0.00 % Shares Percent Shares Out 0.1826 Operating Cashflow -102759000
Currency USD Time Zone Full Name America/New_York Market Cap 1 B
Is_nasdaq_100 False Zip 94080 Quote Type EQUITY
Industry Biotechnology Long Name Structure Therapeutics Inc. Regular Market Day Low 33.09
Held Percent Institutions 1.07 Current Price 33.75 Address2 Suite 900
Enterprise To Ebitda -45.51 Financial Currency USD Current Ratio 41.38
Industry Disp Biotechnology Number Of Analyst Opinions 11 Country United States
Float Shares 153 M Two Hundred Day Average 39.51 Enterprise Value 5 B
Forward PE -53.45 Regular Market Volume 518558 Ebitda -121844000
Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs.

The company's lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity.

It is also developing oral small molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073, a biased agonist for apelin receptor, a GPCR that has been implicated in idiopathic pulmonary fibrosis (IPF); and LTSE-2578, an investigational oral small molecule lysophosphatidic acid 1 receptor antagonist for the treatment of IPF and PPF.

The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.